Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

671.18
+9.191.39%
Number of Gainers:93
Number of Losers:52
Number of Flat:8
PE:- -
High:673.52
Open:662.15
Low:661.43
Close:662.00
Volume:287.29M
Turnover:7.82B
Market Cap:464.24B
Float Cap:356.88B

Loading ...

Blend Head Nima Ghamsari Sells 22,523 Blend Labs Shares for $24,819.35

Reuters
·
Oct 01

Whitehawk Therapeutics initiated with a Buy at Stifel

TIPRANKS
·
Oct 01

Logistic Properties of the Americas Sells Peru’s Parque Logístico Lima Sur for Us$145 Million

Reuters
·
Oct 01

Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

GlobeNewswire
·
Oct 01

Monte Rosa to Present Phase 1 Gforce-1 Data for MRT-8102 in Elevated Cardiovascular Risk Subjects

Reuters
·
Oct 01

Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk

GlobeNewswire
·
Oct 01

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Oct 01

Compass' MLS Cooperation Demand Rejected by the California Regional Multiple Listing Service

MT Newswires Live
·
Oct 01

Moving iMage Technologies Narrows Loss, Advances Toward Profitability

TIPRANKS
·
Oct 01

Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA)

TIPRANKS
·
Oct 01

Robinhood Markets Inc Stock (HOOD) Moved Down by 3.06% on Sep 30: Facts Behind the Movement

TradingKey
·
Oct 01

Judge Blocks New York Rent-Setting Software Ban

Reuters
·
Oct 01

Robinhood Markets Price Target Maintained with a $150.00/Share by Morgan Stanley

Dow Jones
·
Oct 01

Nexxen International Holds Annual General Meeting

Reuters
·
Oct 01

Zeta Global Holdings call volume above normal and directionally bullish

TIPRANKS
·
Oct 01

Open USD launches with over $1B in liquidity commitments

cryptonews
·
Oct 01

Eco Wave Power to Present at Small Cap Showcase Investor Conference

Reuters
·
Oct 01

California Regional MLS Rejects Compass's Demands, Stands Firm on Cooperation & Transparency

Reuters
·
Oct 01

Keros Therapeutics Advances DMD Trial for KER-065, Keeping Rare Disease Upside in Play

TIPRANKS
·
Oct 01

Damora Therapeutics Advances CALR-Targeted Antibody Into Early Clinical Testing

TIPRANKS
·
Oct 01